As expected, the most prevalent somatic alteration in these bladder cancer cell lines was inactivating TP53 mutations, which were present in 14/17 cell lines, typically accompanied by loss of heterozygosity (LOH). Here, TP53 is linked to urinary bladder carcinoma.